Hypomethylating agent (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hypomethylating agent (unspecified), covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia [EARLY_Phase 1]